General Gynecology
Guideline | Perimenopause and Postmenopause – Diagnosis and Interventions.
28 Jun, 2021 | 09:32h | UTC
Review: chronic pelvic pain in women.
17 Jun, 2021 | 09:36h | UTCChronic Pelvic Pain in Women: A Review – JAMA (free for a limited period)
Audio clinical review: Diagnosis and Clinical Care of Women With Chronic Pelvic Pain
Pessaries for pelvic organ prolapse – looking at the Cochrane evidence.
24 May, 2021 | 08:17h | UTCPessaries for pelvic organ prolapse – looking at the Cochrane evidence – Evidently Cochrane
Original Review: Pessaries (mechanical devices) for managing pelvic organ prolapse in women – Cochrane Library
#ACC21 – The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – “The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women”.
18 May, 2021 | 07:32h | UTCHomepage: The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – The Lancet (free registration required)
Infographic: Women and cardiovascular disease
Video: The Lancet women and cardiovascular disease Commission
News release: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030 – The Lancet
Commentary on Twitter (thread – click for more)
Cardiovascular disease is responsible for 35% of deaths in women yearly—yet remains:
❣️Understudied
❣️Under-recognised
❣️Underdiagnosed
❣️UndertreatedNEW @TheLancet Commission outlines 10 recommendations to improve health outcomes for millions of women: https://t.co/DDB97FFunC pic.twitter.com/WjV3aqqLV9
— The Lancet (@TheLancet) May 17, 2021
Large trial with over 200.000 patients finds ovarian cancer screening does not reduce deaths.
14 May, 2021 | 08:32h | UTCCommentaries: Screening for ovarian cancer did not reduce early deaths – Imperial College London AND Annual screening for ovarian cancer does not save lives, study finds – The Guardian
RCT: Community pharmacies provision of a progestogen-only pill + invitation to a sexual and reproductive health clinic as a bridging contraception intervention for women receiving emergency contraception is associated with increased subsequent use of long-term effective contraception.
10 May, 2021 | 00:45h | UTC
Study: Despite clinical practice guidelines recommending cervical cancer screening every 3 years or cotesting with HPV and cytologic testing every 5 years, many women get tested much more often
3 May, 2021 | 05:19h | UTC
AHA Scientific Statement: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormonal therapies
29 Apr, 2021 | 08:33h | UTCNews release: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association
Top Things to Know: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association
Commentaries: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association AND Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association AND Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD AND Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay
M-A: Lidocaine lubricant jelly does not reduce pain perception during female urethral catheterization
27 Apr, 2021 | 09:11h | UTCLidocaine lubricant jelly does not reduce pain perception during female urethral catheterization: A systematic review with meta‐analysis and trial sequential analysis – The International Journal of Clinical Practice (link to abstract – $ for full-text)
Guideline: Prevention of Positioning Injuries During Gynecologic Surgery
25 Apr, 2021 | 20:50h | UTC
RCT: No benefit from immune checkpoint inhibitors in newly diagnosed stage III or IV ovarian cancer
25 Apr, 2021 | 20:57h | UTC
Guideline: Diagnosis and Treatment of Endometriosis
25 Apr, 2021 | 20:46h | UTC
Guideline: Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis)
25 Apr, 2021 | 20:47h | UTC
RCT: Treatments for vulnerable older adult women with ovarian cancer compared
23 Apr, 2021 | 08:15h | UTCEfficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Editorial: Vulnerable Older Adults With Ovarian Cancer—Time to Stop Undertreating (free for a limited period)
Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30
20 Apr, 2021 | 05:42h | UTCRelated USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
30 Mar, 2021 | 03:08h | UTCNews Release: Six pregnancy complications are among red flags for heart disease later in life – American Heart Association
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
28 Mar, 2021 | 22:49h | UTCCovid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ
Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion
Special Issue: The importance of women’s health in peri‐operative care
16 Mar, 2021 | 01:42h | UTCSpecial Issue: The importance of women’s health in peri‐operative care – Anaesthesia
Cohort study: Hypertensive disorders of pregnancy linked to subsequent risk of premature mortality
10 Mar, 2021 | 08:24h | UTCHypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Do Hypertension Disorders of Pregnancy Increase Risk of Premature Maternal Mortality? – American College of Cardiology AND Hypertension disorders of pregnancy increase risk of premature maternal mortality – American College of Cardiology
RCT: Secondary cytoreduction followed by chemotherapy vs. chemotherapy alone in platinum-sensitive relapsed ovarian cancer
10 Mar, 2021 | 08:18h | UTCSecondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentary on Twitter
NEW online: SOC-1 trial—Secondary #cytoreduction followed by #chemotherapy versus chemotherapy alone in platinum-sensitive relapsed #ovariancancer #surgery #gyncsm https://t.co/cFq41Ck9EW pic.twitter.com/5gFsIGLBDA
— The Lancet Oncology (@TheLancetOncol) March 9, 2021
WHO Report | Devastatingly pervasive: 1 in 3 women globally experience violence
10 Mar, 2021 | 08:21h | UTCDevastatingly pervasive: 1 in 3 women globally experience violence – World Health Organization
Commentary: Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever – Health Policy Watch
Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk
11 Mar, 2021 | 08:35h | UTCOriginal study: Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study – Anaesthesia
Commentary on Twitter
Reported by > 100 news organisations and > 200k Twitter impressions in just a few hours!
Here is the new @CovidSurg infographic! Time to establish timing of surgery guidelines?@aneelbhangu @dnepo @JoanaffSimoes #FOAMed
?https://t.co/mRnV7U6u1w pic.twitter.com/BmKlxf9ZIK
— ??????????? (@Anaes_Journal) March 10, 2021
Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance
5 Mar, 2021 | 08:35h | UTCRecommendations: Pharmacovigilance Evidence Review: The effect of COVID-19 vaccines on breast screening – Drug Safety Research Unit
Related: 2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients
USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea in Sexually Active Women
3 Mar, 2021 | 08:43h | UTCScreening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force
ACOG Committee Opinion: Health care for transgender and gender diverse individuals
3 Mar, 2021 | 08:41h | UTCHealth Care for Transgender and Gender Diverse Individuals – Obstetrics & Gynecology